Diagnostics & Imaging
RIVANNA BoneEnhance
Machine learning module for RIVANNA's Accuro XV ultrasound, segmenting bone and surrounding tissue for 3D skeletal visualization.
The Signal
BoneEnhance received FDA 510(k) clearance announced October 22, 2026, as the first machine learning layer on the Accuro XV platform. The Accuro XV system itself was cleared in May 2026 for musculoskeletal imaging. Segmentation supports physician review rather than automated diagnosis.
Company profileMore in Diagnostics & Imaging
VisualDx
A diagnostic clinical decision support system featuring a comprehensive library of medical images.
View toolAidoc
AI platform that flags acute abnormalities in medical images to prioritize urgent patient scans.
View toolViz.ai
AI powered care coordination platform that detects strokes and other acute diseases on imaging scans.
View toolLunit
AI software that analyzes chest x rays and breast mammography scans to detect potential cancers.
View toolPaige AI
AI digital pathology platform assisting pathologists in diagnosing cancer from tissue slides and biopsies.
View tooliRhythm
Continuous cardiac monitoring service utilizing wearable biosensors and AI to detect heart arrhythmias.
View tool